A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
Clinical trial NCT07412236 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07412236
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2028-12-30
- Enrollment
- 1208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.